Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Monitoring of Recovered Solvent Odor and Clarity – V 2.0

Posted on By

API Manufacturing: SOP for Monitoring of Recovered Solvent Odor and Clarity – V 2.0

Standard Operating Procedure for Monitoring of Recovered Solvent Odor and Clarity in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/057/2025
Supersedes SOP/API/057/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the procedure for monitoring the organoleptic properties—odor and clarity—of recovered solvents in API manufacturing, ensuring that only solvent batches meeting specified criteria are reused in production.

2. Scope

This SOP applies to all recovered solvents generated through distillation or purification processes in the API plant, prior to their reuse, reprocessing, or disposal.

3. Responsibilities

  • Production Operators: Collect samples of recovered solvents for visual and odor evaluation.
  • QC Department: Perform clarity inspection and odor assessment against standard references.
  • QA Department: Review results and approve for reuse or recommend re-distillation/disposal.
See also  API Manufacturing: SOP for Preventive Maintenance of Solvent Recovery System - V 2.0

4. Accountability

The QC Manager is accountable for executing and documenting organoleptic evaluations. The QA Manager is responsible for ensuring that recovered solvents meet quality and GMP standards before release.

5. Procedure

5.1 Sampling of Recovered Solvents

  1. After recovery, transfer solvent into clean, labeled sampling containers.
  2. Collect samples in amber glass bottles with tight-fitting caps to avoid odor dissipation.
  3. Label with:
    • Solvent Name
    • Batch Number
    • Date of Recovery
    • Operator Initials

5.2 Odor Evaluation

  1. Carry out odor check in a ventilated area free from interfering odors.
  2. Open sample container gently and sniff from the mouth of the bottle (do not inhale directly).
  3. Compare odor with a fresh reference standard of the same solvent.
  4. Record observations as:
    • No Odor
    • Characteristic Odor
    • Unpleasant/Off Odor
See also  API Manufacturing: SOP for Operator Training on Solvent Safety - V 2.0

5.3 Clarity Evaluation

  1. Pour solvent sample into a colorless glass tube (15–25 mm diameter).
  2. Hold the tube against a white and black background under adequate lighting.
  3. Check for:
    • Particulates
    • Turbidity
    • Color deviations
  4. Record clarity as:
    • Clear
    • Hazy
    • Colored

5.4 Acceptance Criteria

  1. Odor: Must be characteristic and comparable to fresh solvent.
  2. Clarity: Must be clear and free from suspended matter.
  3. If solvent fails either test:
    • Send for re-distillation or discard as per SOP/API/049/2025
    • Document the rejection in “Recovered Solvent Evaluation Log” (Annexure-1)

5.5 Documentation

  1. Record:
    • Solvent name
    • Batch No.
    • Odor & clarity results
    • Approved/Rejected
    • Checked by

    in Annexure-1.

  2. QA to sign off on approved lots in the solvent status label and batch release form.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QC: Quality Control
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice

7. Documents

  1. Recovered Solvent Evaluation Log (Annexure-1)
  2. Reference Solvent Odor and Clarity List

8. References

  • ICH Q7 – GMP Guidelines for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – Finished Pharmaceuticals
  • Internal QC Work Instruction Manual

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Recovered Solvent Evaluation Log

Date Solvent Batch No. Odor Clarity Status Checked By
13/04/2025 Acetone RCV-2025-004 Characteristic Clear Approved

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New Recovery Evaluation Protocol QA Head
13/04/2025 2.0 Clarified Acceptance Criteria and Annexure Format QA Review Update QA Head
See also  API Manufacturing: SOP for Isolation by Filtration - V 2.0
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Biosimilars: SOP for Clone Stability Assessment – V 2.0
Next Post: Aerosol: SOP for Establishing Acceptance Criteria for Cleaning Validation – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version